Unfortunately, MAGE-A3 TCR-T cells were observed not only to attack MAGE-A3-positive tumor cells but also exhibit cytotoxicity against the normal central nervous system through the cross-reactivity to MAGE-A12, which is widely expressed in the human brain (Cameron et al, 2013; Linette et al, 2013). Here, MAGEA3 is linked to neoplasm.